Endothelial prostaglandin and nitric oxide synthesis in atherogenesis and thrombosis

Journal of the Formosan Medical Association

Volumn 95, Issue 9, 1996, Pages 661-666

  Wu, Kenneth K ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

atherosclerosis; cyclooxygenase; nitric oxide; prostacyclin; thrombosis; vascular endothelium

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ATHEROGENESIS; BLOOD VESSEL TONE; DEFENSE MECHANISM; GENE TRANSFER; HUMAN; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIOSCLEROSIS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; THROMBOSIS;

EID: 0030469803     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Wu KK, Hoak JC: A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974;ii:924-6.
2. Wu KK, Hoak JC: Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implication. Thromb Haemost 1976;35:702-11.
3. Wu KK: Platelet hyperaggregability and thrombus in patients with thrombocythemia. Ann Intern Med 1978;88:7-11.
4. Vreeken J, Van Aken WG: Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers. Lancet 1977;1: 1395-7.
5. Dougherty JH, Levy DE, Weeksler BB: Platelet activation in acute cerebral ischaemia. Lancet 1977;i:821-4.
6. FitzGerald GA, Pedersen AK, Patrono C: Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 1983;67:1174-7.
7. Preston FE, Ward JD, Marcola BH, et al: Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1978;i:238-40.
8. Ault KA, Rinder HM, Mitchell JG, et al: Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989;10:448-55.
9. Kaplan KL, Owen J: Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;57:199-202.
10. Shattil SJ, Cunningham M, Hoxie JA: Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-15.
11. Trip MD, Cats VM, Van Capelle FJ, et al: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;323:1549-54.
12. Konstantopoulos K, Grotta JC, Sills C, et al: Shear-induced platelet aggregation in normal subjects and stroke patients. Thromb Haemost 1995;74:1329-34.
13. Ghaddar HM, Cortes J, Salomaa V, et al: Correlation of specific platelet activation markers with carotid arterial wall thickness. Thromb Haemost 1995;74:943-8.
14. Wu KK, Thiagarajian P: Role of endothelium in thrombosis and hemostasis. Annu Rev Med 1996;47:315-31.
15. Jaffe EA, Nachman RL, Becker CG: Culture of human endothelial cells derived from umbilical veins: identification by morpholgical and immunological criteria. J Clin Invest 1973;52:2745-56.
16. Gimbrone MA, Cotran AR, Folkman J: Human vascular endothelial cells in culture: growth and DNA synthesis. J Cell Biol 1974;60:673-84.
17. Vane JR: Prostaglandins and the cardiovascular system. Br Heart J 1983;49:405-9.
18. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
19. Wu KK, Kulmacz RJ, Wang LH, et al: Molecular biology of prostacyclin biosynthesis. In: Rubanyi G, Vane JR, eds. Prostacyclin. Amsterdam: Elsevier Science, 1992:11-23.
20. Wu KK: Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 1995;33:179-207.
21. Funk CD, Funk LB, Kennedy ME, et al: Human platelet/ erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression and chromosomal assignment. FASEB J 1991;5:2304-12.
22. Shimokawa T, Kulmacz RJ, DeWitt DL, et al: Tyrosine 385 of prostaglandin endoperoxicle synthase is required for cyclooxygenase catalysis. J Biol Chem 1990;265:20073-6.
23. Shimokawa T, Smith WL: Essential histidines of prostaglandin endoperoxide synthase. J Biol Chem 1991;266: 6168-73.
24. Shimokawa T, Smith WL: Prostaglandin endoperoxide synthase: the aspirin acetylation region. J Biol Chem 1992;267:12387-92.
25. Tang JL, Zembowicz A, Xu XM, et al: Role of Sp1 in transcriptional activation of human nitric oxide synthase type III gene. Biochem Biophys Res Commun 1995;213:673-80.
26. Pereira B, Wu KK, Wang LH: Molecular cloning and characterization of bovine prostacyclin synthase. Biochem Biophys Res Commun 1994;203:59-66.
27. 2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGL binding and stabilizing protein in human blood. Biochem Biophys Acta 1991;1115:131-40.
28. Yokoyama C, Tanabe T: Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989;165:888-94.
29. Wang LH, Hajibeigi A, Xu XM, et al: Characterization of the promoter of human prostaglandin H synthase-1 gene. Biochem Biophys Res Commun 1993;190:406-11.
30. Marsden PA, Heng HHQ, Scherer SW, et al: Structure and chromosomal localization of the human constitutive endothelial NO synthase. J Biol Chem 1993;268:17478-88.
31. Xu XM, Tang JL, Hajibeigi A, et al: Transcriptional regulation of endothelial constitutive PGHS-1 expression by phorbol ester. Am J Physiol 1996;270:C259-64.
32. 2 activity in endothelial cell-induced modification of low density lipoproteins. Proc Natl Acad Sci USA 1985;82:3000-4.
33. Portman OW, Alexander M: Lysophosphatidycholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res 1969;10:158-65.
34. Quinn MT, Parthasarathy S, Steinberg D: Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential in atherogenesis. Proc Natl Acad Sci USA 1988;85:2805-9.
35. Zembowicz A, Jones SL, Wu KK: Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest 1995;96:1688-92.
36. Zembowicz A, Tang JL, Wu KK: Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem 1995;270:17006-10.
37. Xu XM, Ohashi K, Sanduja SK, et al: Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA. J Clin Invest 1993;91:1843-9.
38. Sanduja SK, Tsai AL, Matijevic-Aleksic N, et al: Kinetics of prostacyclin synthesis in PGHS-1 overexpressed endothelial cell. Am J Physiol 1994;267:C1459-6.
39. Herz J, Gerard RD: Adenovirus-mediated transfer of LDL receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993;980: 2812-6.
40. Zoldhelyi P, McNatt J, Xu XM, et al: Prevention of arterial thrombosis by adenovirus mediated transfer of cyclooxygenase-1 gene. Circulation 1996;93:792-9.
41. Yonder Leyen HE, Gibbons GH, Morishita R, et al: Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase. Proc Natl Acad USA 1995;92:1137-41.